Sarepta Therapeutics Inc Q2 2021 Earnings Call Summary - Thomson StreetEvents

Sarepta Therapeutics Inc Q2 2021 Earnings Call Summary

Sarepta Therapeutics Inc Q2 2021 Earnings Call Summary - Thomson StreetEvents
Sarepta Therapeutics Inc Q2 2021 Earnings Call Summary
Published Aug 04, 2021
25 pages (15096 words) — Published Aug 04, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of SRPT.OQ earnings conference call or presentation 4-Aug-21 8:30pm GMT

  
Brief Excerpt:

...A. Introduction: With large multi-platform genetic medicine pipeline, which spans RNA, gene therapy and gene editing and with three approved therapies, SRPT has a significant number of important initiatives underway in 2021. 1. 2. SRPT team's focus on execution and consistent achievement of goals this year is reflected in results. B. SRP-9001: Co. made progress with respect to SRP-9001 and had positive outcome in recently-completed meeting with FDA's Office of Tissues and Advanced Therapies (OTAT). 1. 2. Earlier in 2Q21 SRPT announced 12-week results of its first 11-patient cohort for Study 103, ENDEAVOR. Study 103 is Co.'s trial evaluating the expression and safety of its commercially-representative material. a. An extremely important study as it has confirmed performance of Co.'s therapy using the material process with which it intends to launch SRP-9001. i. b. On every biomarker, Co.'s commercially-representative material performs as well as or better than the clinical supply material...

  
Report Type:

Brief

Source:
Company:
Sarepta Therapeutics Inc
Ticker
SRPT.OQ
Time
8:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Sarepta Therapeutics Inc Q3 2021 Earnings Call Summary – 2021-11-03 – US$ 54.00 – Edited Brief of SRPT.OQ earnings conference call or presentation 3-Nov-21 8:30pm GMT

Sarepta Therapeutics Inc to host SRP-9001 Micro-dystrophin R&D Day Transcript – 2021-10-11 – US$ 54.00 – Edited Transcript of SRPT.OQ corporate analyst meeting</ 11-Oct-21 12:30pm GMT

Sarepta Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript – 2021-09-27 – US$ 54.00 – Edited Transcript of SRPT.OQ presentation 27-Sep-21 5:20pm GMT

Sarepta Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript – 2021-09-13 – US$ 54.00 – Edited Transcript of SRPT.OQ presentation 13-Sep-21 5:15pm GMT

Sarepta Therapeutics Inc Q2 2021 Earnings Call Transcript – 2021-08-04 – US$ 54.00 – Edited Transcript of SRPT.OQ earnings conference call or presentation 4-Aug-21 8:30pm GMT

Sarepta Therapeutics Inc at Bank of America NAPA Healthcare Conference Transcript – 2021-06-16 – US$ 54.00 – Edited Transcript of SRPT.OQ presentation 16-Jun-21 2:30pm GMT

Sarepta Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript – 2021-06-10 – US$ 54.00 – Edited Transcript of SRPT.OQ presentation 10-Jun-21 5:20pm GMT

Sarepta Therapeutics Inc Annual Shareholders Meeting Transcript – 2021-06-03 – US$ 54.00 – Edited Transcript of SRPT.OQ shareholder or annual meeting 3-Jun-21 1:00pm GMT

Sarepta Therapeutics Inc Clinical Update: Study SRP-9001-103: 12-Week Expression and Safety Data Using Commercially Representative Material - Call Summary – 2021-05-18 – US$ 54.00 – Edited Brief of SRPT.OQ conference call or presentation 18-May-21 12:30pm GMT

Sarepta Therapeutics Inc at RBC Capital Markets Global Healthcare Conference (Virtual) Transcript – 2021-05-18 – US$ 54.00 – Edited Transcript of SRPT.OQ presentation 18-May-21 6:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Sarepta Therapeutics Inc Q2 2021 Earnings Call Summary" Aug 04, 2021. Alacra Store. May 18, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2021-Sarepta-Therapeutics-Inc-Earnings-Call-B14934288>
  
APA:
Thomson StreetEvents. (2021). Sarepta Therapeutics Inc Q2 2021 Earnings Call Summary Aug 04, 2021. New York, NY: Alacra Store. Retrieved May 18, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2021-Sarepta-Therapeutics-Inc-Earnings-Call-B14934288>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.